Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors
- CAMARDA, Valeria
- SONG W.
- MARZOLA, Erika
- SPAGNOL, Martina
- GUERRINI, Remo
- SALVADORI, Severo
- REGOLI, Domenico
- THOMPSON J. P.
- ROWBOTHAM D. J.
- BEHM D. J.
- DOUGLAS S. A.
- CALO', Girolamo
- LAMBERT D. G.
Publication date
January 2004
DOI ISSN
0014-2999 Citation count (estimate)
55Abstract
Urotensin-II is the natural ligand of the UT receptor. This novel system is involved in the regulation of cardiovascular functions. Recently, a urotensin-II analog ([Pen5,DTrp7,Orn8]urotensin-II(4-11)) named urantide, has been proposed as a selective and potent UT receptor antagonist. In order to pharmacologically characterize this new compound, urantide was tested on the native UT receptors of the rat aorta and on the human recombinant receptors expressed in CHO cells (CHOhUT). Indeed, urantide behaves as a competitive, potent (pA2 8.24), and pure antagonist in the rat aorta bioassay, while as an agonist (pEC50 8.11) in a calcium mobilization assay performed in CHOhUT cells. Urantide should be considered a low efficacy partial agonist
Add to ORKG